Extracorporeal Membrane Oxygenation Machine (ECMO) Market Overview
The Extracorporeal Membrane Oxygenation Machine (ECMO) Market is expected to grow at a CAGR of 5.10% to reach USD 430 Million during the forecast period (2022 to 2030).
Patients who face difficulty to supply adequate oxygen to the heart and lungs in their body, gets help from Extracorporeal Membrane Oxygenation Machine. It provides respiratory support thus act as a life support machine to many people. A proper respiratory functioning is crucial for people suffering from life-threatening diseases; therefore, the Extracorporeal Membrane Oxygenation Machine comes to their use. The growing number of cardiovascular diseases and respiratory problems and the rapid increase in adoption of ECMO is the driving factor behind the growth of the extracorporeal membrane oxygenation machine market. Along with adoption of ECMO, increasing ECMO centres are also boosting the global market of ECMO.
According to the survey reports provided by the World Health Organisation (WHO), approx 306 hospitals in U.S had the facility of Extracorporeal Membrane Oxygenation Machine to provide respiratory support to people suffering from heart and lung diseases.
Complications regarding the usage of Extracorporeal Membrane Oxygenation Machine such as infections, bleeding or any kind of technical failure are prone to hinder the growth of extracorporeal membrane oxygenation (ecmo) machine market.
The covid-19 pandemic has an impeccable effect all across the world. Many industries all around the globe has been affected by the sudden and infinite shutdown decision taken by the government. Many health industries have also been affected. However, the ECMO industry has seen positive impact during the pandemic situation.
The rising prevalence of diseases causing deaths are driving the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. Based on the reports of World Health Organisation (WHO), in 2012, around 17.5 millions died of Cardiovascular diseases all across the world. And, the number is anticipated to become more than 23.6 million by the end of 2030. It makes cardiovascular diseases as one of the leading causes behind the global death which is also boosting the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. Another prevalent disease is hypertension. It was the leading causes behind the cardiovascular diseases. According to WHO, in 2013, around 1 billion were suffering from hypertension. WHO also reported that chronic obstructive pulmonary diseases caused 3% of the entire deaths caused across the globe. Tobacco smoking and asthma are two of the major causes behind the increasing COPD which is also expected to rise high in the coming years.
ECMO is used to support people with all the cardiovascular problems. Therefore, the rising cases of such situations are the driving factors behind the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market.
Although it works as a support system to patients of respiratory and cardiac problems, but the machine sometimes shows various complications. For example, bleeding is the one of the most common complications associated with ECMO. The bleeding mainly happens because of a blood thinning drug called Heparin. Another complication associated with the extracorporeal membrane oxygenation machine (ecmo) is infection. Infections mostly occur because of the cannula being inserted in the blood vessels. Apart from that, the chances of a patient being infected increases drastically when he or she stays for a longer period of time in the hospital. Technical failure of the machine is also enlisted in all the complications related to the machine. About 4% of the mechanical failures happen because of air entering the ECMO circuit.
Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights
The market of Extracorporeal Membrane Oxygenation Machine is segmented into-
Extracorporeal Membrane Oxygenation Machine Component Insights
Base on component, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-
The oxygenator segment is expected to hold the largest market share of Extracorporeal Membrane Oxygenation Machine.
Extracorporeal Membrane Oxygenation Machine Modality Insights
Base on modality, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-
- Veno-Arterial (VA)
- Veno-Venous (VV)
- Arterio-Venous (AV)
The Veno-Arterial (VA) segment is expected to hold the largest market share of Extracorporeal Membrane Oxygenation Machine.
Extracorporeal Membrane Oxygenation Machine Application Insights
Base on application, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
The respiratory segment is expected to hold the largest market share of Extracorporeal Membrane Oxygenation Machine.
Extracorporeal Membrane Oxygenation Machine Region Insights
Base on region, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
MEA (Middle East and Africa)
The North American market is expected to become the largest market for extracorporeal membrane oxygenation machine (ecmo). The rising diseases like lung cancer, increasing investment in research and developments, reimbursement scenarios are likely to boost the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. U.S is the most dominating country of this region as it has the highest number of lung cancer. Therefore, the need for the ECMO is also highest in U.S. Apart from lung cancer, around 11 million people are diagnosed with COPD every year in U.S. Canada is also high in demand for the extracorporeal membrane oxygenation machine (ecmo).
The European extracorporeal membrane oxygenation machine (ecmo) market is about to show a substantial growth during the forecast period. It has the presence of many healthcare systems and rising chronic diseases, are driving the market growth of the region. Many key players being present in the market and their investments in research and developments is also propelling the growth of the European extracorporeal membrane oxygenation machine (ecmo) market.
The Asia-Pacific is anticipated to be the fastest-growing region in the extracorporeal membrane oxygenation machine (ecmo) market. The rising cases of lung cancer and cardiovascular diseases are also boosting the growth of the market. In China, 35.1% of the entire population are diagnosed with lung cancer every year. The favourable reimbursement scenario in Japan, growing ECMO service centres in India, and rising cases of lung cancer in China are proving the impetus to the Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market.
The MEA market of extracorporeal membrane oxygenation machine (ecmo) is expected to see the lowest growth among all the other regional markets.
Major key players
- Getinge Group (sweden)
- Medtronic plc (Ireland)
- Livanova PLC (U.K)
- Abbott, Agilent Technologies
- Siemens AG
- Terumo Corporation (Japan),
- Fresenius Medical Care AG & Co. KGaA
- Microport Scientific Corporation (China)
- Nipro Corporation (Japan)
- ALung Technologies Inc. (Germany)
- MAQUET Holding B.V. & Co. KG
- Medos Medizintechnik AG
- Terumo Cardiovascular Systems Corp
- XENIOS AG (Germany)
- OriGen Biomedical, Inc. (U.S.)
- EUROSETS S.r.l. (Italy)
- Market overview
- Covid-19 impact
- Market dynamics
- Technological analysis
- Segmentation overview
- Regional analysis
- Competitive landscape
- Recent developments
- Major key players
| Market Size in 2030
| USD 430 Million
| Base Year
| Forecast Period
| Historical Data
| Forecast Units
| Value (USD Million)
| Report Coverage
| Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
| Segments Covered
| Component, Modality, Application
| Geographies Covered
| North America, Europe, Asia-Pacific, and Rest of the World (RoW)
| Key Vendors
| Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp
| Key Market Opportunities
| Increasing investment in research and development of new medical devices
| Key Market Drivers
| The increasing prevalence of cardiovascular concerns
Extracorporeal Membrane Oxygenation Machine Market Highlights:
Frequently Asked Questions (FAQ) :
global market was valued at 267.6 million in 2018.
Extracorporeal Membrane Oxygenation Machine (ECMO) Marketis expected to exhibit a solid 5.10% CAGR over the forecast period from 2022 to 2030.
The increasing prevalence of cardiovascular concerns is the major driver for the global extracorporeal membrane oxygenation machine market.
The Americas market is expected to hold the largest share in the market.
Leading players in the extracorporeal membrane oxygenation machine market include Getinge Group, Agilent, Abbott, and Siemens, among others.
Key Questions Answered
Request Free Sample
- ✅Global Market Outlook
- ✅In-depth analysis of global and regional trends
- ✅Analyze and identify the major players in the market, their market share, key developments, etc.
- ✅To understand the capability of the major players based on products offered, financials, and strategies.
- ✅Identify disrupting products, companies, and trends.
- ✅To identify opportunities in the market.
- ✅Analyze the key challenges in the market.
- ✅Analyze the regional penetration of players, products, and services in the market.
- ✅Comparison of major players’ financial performance.
- ✅Evaluate strategies adopted by major players.
Why Choose Market Research Future?
Speak to Analyst
- ✅Vigorous research methodologies for specific market.
- ✅Knowledge partners across the globe
- ✅Large network of partner consultants.
- ✅Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- ✅Trusted by fortune 500 companies/startups/universities/organizations
- ✅Large database of 5000+ markets reports.
- ✅Effective and prompt pre- and post-sales support.